Treatment Options
Researching Cinnamon's Possible Diabetes Benefits
10/12/07
Treatment Options, Diagnosis, Research
While the latest study on cinnamon shows that it does not help diabetes, it may not be time to dismiss the tasty spice altogether.
A recent edition of the the journal Diabetes Care reported on a study that tested doses of cinnamon to determine if it could help people with diabetes. The study found that cinnamon did not reduce blood sugar, improve insulin resistance, or lower cholesterol.
Overview of Recent Thiazolidinedione News
10/04/07
Treatment Options
It has been a topsy turvey month for people with diabetes that have been taking Avandia (rosiglitazone) and Actos(pioglitazone). There has been a lot of new information about these drugs, commonly called thiazolidinediones, from very reputable sources including JAMA and the European Association for the Study of Diabetes. We want to summarize what the world of medical science has concluded during the last few weeks.
Hoodia for Weight Control - Little Information
10/04/07
Treatment Options
Though many people tout hoodia as the latest herbal weight loss aid, one national agency has stated: "There is no reliable scientific evidence to support hoodia's use."
Study Reaffirms Fewer Heart Attacks with Actos
09/25/07
Treatment Options
The news about Actos just keeps getting better. In a presentation last week at the 43rd Annual Meeting of the European Association for the Study of Diabetes, a study derived from an insurance claims database indicated that Actos reduced the risk of cardiovascular disease in patients with type 2 diabetes. In this case it stated that Actos specifically reduces ischemic heart disease , or heart disease related to inadequated blood flow to the heart. This comes just days after a JAMA article arguing that Actos reduces the risk of heart attack, stroke, and death.
This Diabetes Web Site is For You
09/21/07
Treatment Options
By Matt Nilsen
Recently I was talking with someone who was searching for information because she was confronting prediabetes, in spite of an aggressive exercise regimen. She asked me about strategies she should employ and wanted to know if she could beat diabetes. I told her she should be working closely with her doctor to develop strategies for her specific form of diabetes. It may be time for her to start an antidiabetes medication like metformin. I also said that if she develops diabetes, she should not postpone starting insulin early. It is likely to help her pancreas stay viable longer.
Battling Third Cause of Type 2 Diabetes
09/13/07
Prediabetes and Impaired Glucose Tolerance, Type II Diabetes, Nutrition & Exercise, Living Well, Treatment Options, Prevention, General
Since the scientific identified a third cause of type 2 diabetes, we have to ask the question, how do we battle it? It may be too early for answers, but it is a great time to ask .
Diabetes is a problem that arises when one or both of the following conditions occur:
- A person's body cannot make enough insulin.
- A person's body is not able to use the insulin it produces to process blood sugar
Pioglitazone Reduced Heart Attack, Increased Heat Failure
09/11/07
Diabetes Medications, Prediabetes and Impaired Glucose Tolerance, Type II Diabetes, Treatment Options, Prevention, General
CHICAGO – It is hard to know which medications to use to lower blood glucose levels. Beside their potency as anti-diabetes medications, diabetics must also consider side effects. Many of them are potentially serious.
A study combining previous research suggests that use of pioglitazone, marketed as brand name Actos, significantly reduces the risk of heart attack, stroke, and death, but increases the risk for serious heart failure, according to an article in the September 12 issue of JAMA. The risk of heart failure is low, while the reduction in heart attack rate is high. As a result, we suspect that many doctors will be migrating their patients to Actos (brand name for pioglitazone).
American Association of Clinical Endocrinologists Releases Revised Guidelines
09/06/07
Diabetes Medications, Prediabetes and Impaired Glucose Tolerance, Type II Diabetes, Type I Diabetes or Juvenile Diabetes, Living Well, Treatment Options, Prevention, Disease Basics, General
After scouring the 66 pages of the newly revised Medical Guidelines for Clinical Practice for the Management of Diabetes Mellitus, just released by the American Association of Clinical Endocrinologists (AACE), we want to introduce some of the content. In contrast to other medical guidelines, this set of diabetes guidelines is refreshingly specific and direct. It has exact recommendations for patients living with either type 1 or type 2 diabetes. We want to share some wisdom from this document and recommend some places to start researching.
Symlin—Part of the Diabetes Hormone Balancing Act
09/06/07
Diabetes Medications, Type II Diabetes, Type I Diabetes or Juvenile Diabetes, Treatment Options, General
In 1987, an Oxford University research team isolated a hormone produced in the pancreas that was later named amylin. As their research persisted, scientists learned that amylin delays the time it takes for the stomach to empty into the intestines, and delays sugar transfer from the digestive system to the blood stream. It also slows the liver's production of glucose. Scientists found that type 1 diabetics often produce little or no amylin, and type 2 diabetics make less amylin.
Making Sense of Blood Sugar Readings
09/06/07
Type II Diabetes, Type I Diabetes or Juvenile Diabetes, Treatment Options, Disease Basics, General
Diabetes introduces people to a whole new life complete with different rituals, a new language, and metrics that can be confusing. According to a recent story from a Las Vegas television station, many people do not know how to interpret their blood sugar measures.